Nigella sativa pharmacological applications

Nigella sativa, a flowering plant long used in traditional medicine across the Middle East and South Asia, has attracted growing scientific attention for the range of biological effects attributed to its seeds and their principal active compound, thymoquinone. Researchers are working to characterize how thymoquinone exerts antioxidant, anti-inflammatory, and immunomodulatory effects at the molecular level, and to assess whether these mechanisms translate into meaningful therapeutic outcomes in conditions such as cancer, type 2 diabetes, and neurodegenerative disease. A central challenge is establishing reliable dose-response relationships and understanding the toxicological profile of both the whole seed extract and isolated thymoquinone, since bioavailability and stability vary considerably across formulations. Much current work is directed toward improving delivery systems and conducting rigorous clinical trials that can determine whether the promising results seen in cell and animal studies hold up in human patients.

Works

16,250

Total citations

183,840

Keywords

Nigella sativaThymoquinoneAntioxidantAnti-inflammatoryCancerImmunomodulatory